cetrimonium bromide has been researched along with benzethonium chloride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devínsky, F; Garajová, M; Haragová, H; Kubincová, J; Lukáč, M; Mojžiš, J; Mojžišová, G; Mrva, M; Ondriska, F; Sabol, M; Varinská, L | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Kumar, A; Lyu, Y; Schweizer, F; Yang, X; Zhanel, GG | 1 |
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
3 other study(ies) available for cetrimonium bromide and benzethonium chloride
Article | Year |
---|---|
Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride.
Topics: Antifungal Agents; Antineoplastic Agents; Benzalkonium Compounds; Benzethonium; Candida albicans; Cell Line, Tumor; Cell Proliferation; Cetrimonium; Cetrimonium Compounds; Cetylpyridinium; Chemistry Techniques, Synthetic; Humans; Micelles; Phosphorylcholine; Structure-Activity Relationship; Surface Properties | 2013 |
A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
Topics: Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Membrane Transport Proteins; Tobramycin | 2017 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |